The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life

NCT05991128 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction
Iron Deficiencies
Acute Heart Failure

Interventions

DRUG: Ferric derisomaltose
DRUG: Placebo

Sponsor

China-Japan Friendship Hospital